Armata Pharmaceuticals (ARMP) Research & Development (2013 - 2026)

Armata Pharmaceuticals has disclosed Research & Development across 14 years of filings, most recently posting $7.6 million for Q2 2026.

• In Q2 2026, Research & Development rose 18.64% year-over-year to $7.6 million; the TTM figure through Jun 2026 stood at $25.6 million (down 14.01% YoY), while the FY2025 annual figure was $23.7 million, down 31.11% from the prior year.
• Research & Development came in at $7.6 million for Q2 2026 at Armata Pharmaceuticals, up from $6.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $9.6 million in Q1 2023 to a low of $5.4 million in Q1 2025.
• Average Research & Development over 5 years is $7.8 million, with a median of $8.0 million recorded in 2022.
• Year-over-year, Research & Development surged 98.77% in 2022 and sank 38.6% in 2025.
• Over 5 years, Research & Development stood at $9.6 million in 2022, then slipped by 17.15% to $7.9 million in 2023, then gained by 6.6% to $8.5 million in 2024, then dropped by 28.17% to $6.1 million in 2025, then increased by 24.98% to $7.6 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $7.6 million in Q2 2026, $6.1 million in Q1 2026, and $6.1 million in Q4 2025.